Back
Amgen Quote, Financials, Valuation and Earnings
Sponsored
AMGN
Sponsored
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
42
AMGN
Amgen
Last Price:
283.64
Seasonality Move:
9.84%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.Amgen Price Quote
$283.64
+0.03 (+-4.15%)
(Updated: November 16, 2024 at 5:07 AM ET)
Amgen Key Stats
Sell
42
Amgen (AMGN)
is a Sell
Day range:
$279.62 - $291.50
52-week range:
$260.52 - $346.85
Dividend yield:
3.13%
P/E ratio:
22.71
P/S ratio:
4.70
P/B ratio:
20.25%
Volume:
5.2M
Avg. volume:
2.2M
1-year change:
3.88%
Market cap:
$152.4B
Revenue:
$28.2B
EPS:
$7.81
How Much Does Amgen Make?
Is Amgen Growing As A Company?
Amgen Stock Price Performance
What Is Amgen 52-Week High & Low?
Amgen Price To Free Cash Flow
-
Is Amgen Stock Overvalued?
Amgen is trading at a price to free cash flow ratio of 24.34 -
Is Amgen Stock Undervalued?
Amgen EV to Free Cash Flow ratio is 32.44 -
What Is Amgen’s Price Earnings Growth Ratio?
AMGN PEG ratio is 0.00 -
Is Amgen Trading At A Premium To Earnings?
Amgen EV to EBIT ratio is 25.78
Is It Risky To Buy Amgen?
Is Amgen Cash Flow Positive?
Amgen Return On Invested Capital
Amgen Earnings Date & Stock Price
-
What Is Amgen's Stock Price Today?
A single share of AMGN can be purchased today for 283.61 -
What Is Amgen’s Stock Symbol?
Amgen trades on the S&P500 under the ticker symbol: AMGN -
When Is Amgen’s Next Earnings Date?
The next quarterly earnings date for Amgen is scheduled on February 6, 2025 -
When Is AMGN's next ex-dividend date?
Amgen's next ex-dividend date is November 18, 2024 -
How To Buy Amgen Stock?
You can buy Amgen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Amgen Competitors
Amgen Dividend Yield
Amgen Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 62.11% | 9.29% |
Revenue: | 23.18% | 0.05% |
Analyst Recommendations
Buy Recommendations: | 10 |
---|---|
Hold Recommendations: | 17 |
Sell Recommendations: | 2 |
Price Target: | 334.06 |
Upside from Last Price: | 17.79% |